Literature DB >> 21138434

The identification of N-glycosylated residues of the human 5-HT3B receptor subunit: importance for cell membrane expression.

Andrew N Massoura1, Terri J Dover, Amy S Newman, Nicholas M Barnes.   

Abstract

The 5-hydroxytryptamine 3 (5-HT(3)) receptor is a pentameric ligand-gated ion channel with potential molecular isoforms arising from different subunit combinations and/or different post-translational modifications of the individual subunits. Since N-glycosylation of the 5-HT3A subunit impacts cell surface trafficking, the presence of N-glycosylation of the human (h) 5-HT3B subunit and the influence upon cell membrane expression was investigated. Following transient expression of the h5-HT3B subunit by human embryonic kidney cells (HEK293 cells) stably expressing the h5-HT3A subunit, the N-glycosylation inhibitor tunicamycin reduced the size of the predominant h5-HT3B-immunoreactive protein (∼ 55 kDa reduced to ∼ 40 kDa). Disruption of each consensus N-glycosylation sequences in the h5-HT3B subunit (N31S, N75S, N117S, N147S and N182S) resulted in a reduced molecular weight (by ∼ 2-4 kDa) of each mutant when expressed by HEK293 cells stably expressing the h5-HT3A subunit. Immunocytochemical studies demonstrated that disruption of each of the N-glycosylation sequences (individually or combined) reduced the expression of the mutant h5-HT3B subunit protein in the cell membrane when co-expressed with the h5-HT3A subunit. The present study has identified utilised N-glycosylation sites of the h5-HT3B subunit and demonstrated that they promote subunit expression in the cell membrane; a prerequisite for 5-HT(3) receptor function.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21138434     DOI: 10.1111/j.1471-4159.2010.07129.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production.

Authors:  Yogesh Bhattarai; Bradley A Schmidt; David R Linden; Eric D Larson; Madhusudan Grover; Arthur Beyder; Gianrico Farrugia; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-13       Impact factor: 4.052

2.  Association, interaction, and replication analysis of genes encoding serotonin transporter and 5-HT3 receptor subunits A and B in alcohol dependence.

Authors:  Chamindi Seneviratne; Jason Franklin; Katherine Beckett; Jennie Z Ma; Nassima Ait-Daoud; Thomas J Payne; Bankole A Johnson; Ming D Li
Journal:  Hum Genet       Date:  2013-06-12       Impact factor: 4.132

3.  The 5-HT3AB receptor shows an A3B2 stoichiometry at the plasma membrane.

Authors:  Timothy F Miles; Dennis A Dougherty; Henry A Lester
Journal:  Biophys J       Date:  2013-08-20       Impact factor: 4.033

Review 4.  Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses.

Authors:  Helen Irving; Ilona Turek; Christine Kettle; Nor Yaakob
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

5.  Molecular neurobiological markers in the onset of sodium appetite.

Authors:  Cintia Y Porcari; María J Cambiasso; André S Mecawi; Ximena E Caeiro; José Antunes-Rodrigues; Laura M Vivas; Andrea Godino
Journal:  Sci Rep       Date:  2022-08-20       Impact factor: 4.996

6.  Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization.

Authors:  J Daniel Hothersall; Christopher Moffat; Christopher N Connolly
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 7.  5-HT Receptors and Temperature Homeostasis.

Authors:  Irina P Voronova
Journal:  Biomolecules       Date:  2021-12-20

8.  Sexual dimorphic impacts of systemic vincristine on lower urinary tract function.

Authors:  Nao Iguchi; Sarah L Hecht; Dexiang Gao; Duncan T Wilcox; Anna P Malykhina; Nicholas G Cost
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.